Rice Hall James & Associates’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $29.2M | Sell |
|
|||||
|
2025
Q2 | $27.6M | Sell |
|
|||||
|
2025
Q1 | $25.1M | Sell |
|
|||||
|
2024
Q4 | $22.6M | Buy |
|
|||||
|
2024
Q3 | $24M | Buy |
|
|||||
|
2024
Q2 | $20.7M | Sell |
|
|||||
|
2024
Q1 | $24.6M | Sell |
|
|||||
|
2023
Q4 | $21.3M | Sell |
|
|||||
|
2023
Q3 | $15.9M | Sell |
|
|||||
|
2023
Q2 | $15.5M | Buy |
|
|||||
|
2023
Q1 | $16.6M | Buy |
|
|||||
|
2022
Q4 | $17.8M | Buy |
|
|||||
|
2022
Q3 | $14.1M | Sell |
|
|||||
|
2022
Q2 | $15.2M | Buy |
|
|||||
|
2022
Q1 | $15.8M | Buy |
|
|||||
|
2021
Q4 | $13.4M | Buy |
|
|||||
|
2021
Q3 | $12.2M | Buy |
|
|||||
|
2021
Q2 | $5.29M | Hold |
|
|||||
|
2021
Q1 | $5.18M | Sell |
|
|||||
|
2020
Q4 | $7M | Buy |
|
|||||
|
2020
Q3 | $3.44M | Buy |
|